More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Upsalite® has proven great potential for development of new formulations of these rejected drugs.
Read the article:
Or read the press release

Verified by MonsterInsights